FDG-PET for Early Response Assessment in Lymphomas PART 1: Hodgkin Lymphoma

被引：0

作者：

Cheson, Bruce D. ^{[1
,2
,3
,4
]}

Kostakoglu, Lale ^{[5
,6
,7
]}

机构：

[1] Georgetown Lombardi Comprehens Canc Ctr, Med, Washington, DC 20523 USA

[2] Georgetown Lombardi Comprehens Canc Ctr, Hematol, Washington, DC 20523 USA

[3] Georgetown Lombardi Comprehens Canc Ctr, Div Hematol Oncol, Washington, DC 20523 USA

[4] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20523 USA

[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[6] Icahn Sch Med Mt Sinai, Nucl Med & Mol Imaging, New York, NY 10029 USA

[7] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA

来源：

ONCOLOGY-NEW YORK | 2017年 / 31卷 / 01期

关键词：

POSITRON-EMISSION-TOMOGRAPHY; INTERIM-PET; PROGNOSTIC VALUE; INTERPRETATION CRITERIA; RADIATION-THERAPY; PREDICT RESPONSE; CELL LYMPHOMA; FREE SURVIVAL; F-18-FDG PET; CYCLES;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Interim positron emission tomography (PET)/CT has shown encouraging results when used as a prognostic tool early in the course of treatment of advanced Hodgkin lymphoma, allowing for a reduction in treatment for patients with favorable characteristics, while suggesting a benefit from changing therapy for those with a positive scan. For patients with limited disease, a negative scan allows for a decrease in treatment; however, the benefits for those patients whose scans are positive are less certain. Here we critically analyze the role of PET/CT in the early assessment of Hodgkin lymphoma. In Part 2, we will review the role of interim PET/CT in diffuse large B-cell lymphoma (DLBCL), and also explore the question of whether new approaches to quantitative assessment improve the prognostic value of interim PET scans in both Hodgkin lymphoma and DLBCL.

引用

页码：45 / 49

页数：5

共 50 条

[1] FDG-PET in Hodgkin lymphoma
Kobe, C.
Dietlein, M.
Mauz-Koerholz, C.
Engert, A.
Borchmann, P.
Sabri, O.
Schober, O.
Schicha, H.
Kluge, R.
NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2008, 47 (06): : 235 - 238
[2] FDG-PET in Hodgkin Lymphoma
Hutchings, M.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S16 - S16
[3] FDG-PET for Early Response Assessment in Lymphomas PART 2: Diffuse Large B-Cell Lymphoma, Use of Quantitative PET Evaluation
Cheson, Bruce D.
Kostakoglu, Lale
ONCOLOGY-NEW YORK, 2017, 31 (01): : 71 - 76
[4] FDG-PET in Hodgkin's lymphoma
Ruth Kirby
Nature Clinical Practice Oncology, 2005, 2 (10): : 485 - 486
[5] FDG-PET for assessment of early therapy response after 4 cycles of chemotherapy in advanced stage Hodgkin lymphoma
Markova, J.
Skopalova, M.
Kobe, C.
Klaskova, K.
Zikavska, L.
Polivka, J.
Vernerova, Z.
Kamaradova, K.
Dedeckova, K.
Kozak, T.
ANNALS OF ONCOLOGY, 2008, 19 : 135 - 135
[6] Interim FDG-PET/CT for Response Assessment of Lymphoma
Zeman, Merissa N.
Akin, Esma A.
Merryman, Reid W.
Jacene, Heather A.
SEMINARS IN NUCLEAR MEDICINE, 2023, 53 (03) : 371 - 388
[7] Assessment of therapy response in lymphoma: Role of FDG-PET
Julian, A.
Wagner, T.
Payoux, P.
Hitzel, A.
Esquerre, J. -P.
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2011, 35 (01): : 21 - 28
[8] FDG-PET scan and treatment planning for early stage Hodgkin lymphoma
Specht, Lena
RADIOTHERAPY AND ONCOLOGY, 2007, 85 (02) : 176 - 177
[9] Predictive role of Early Interim FDG-PET in Hodgkin Lymphoma.
Stefoni, Vittorio
Broccoli, Alessandro
Alinari, Lapo
Ambrosini, Valentina
Derenzini, Enrico
Fanti, Stefano
Fina, Mariapaola
Gandolfi, Letizia
Marchi, Enrica
Pellegrini, Cinzia
Quirini, Federica
Zinzani, Pier Luigi
Baccarani, Michele
BLOOD, 2009, 114 (22) : 662 - 662
[10] FDG-PET in the clinical management of Hodgkin lymphoma
Hutchings, M
Eigtved, AI
Specht, L
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 52 (01) : 19 - 32

← 1 2 3 4 5 →